Along similar lines, in an animal study, MOTS-c therapy was administeredto mice with gestational diabetes mellitus, which resulted in a significantimprovement in hyperglycemia, insulin sensitivity, and glucose tolerance (23). Here, INS is linked to gestational diabetes.